MMP2 and myeloid sarcoma: MMP2, a protein that reflects high levels of grey matter damage in MS patients (Magliozzi et al., 2018), has been confirmed to cause blood-brain barrier disruption, basal layer remodeling (Aksoy et al., 2016).